Aeromics

Q: What is Aeromics's official website?

Aeromics's official website is www.aeromics.com

Q: What is Aeromics's Revenue?

Aeromics's revenue is <$5 Million

Q: What industry does Aeromics belong to?

Aeromics is in the industry of: Manufacturing , Pharmaceuticals , Business Services

Q: What is Aeromics competition?

Aeromics top competitors include: Moleculin , AdAlta , Inhibikase Therapeutics , NuvOx Pharma

Q: What technology does Aeromics use?

Some of the popular technologies that Aeromics uses are: Squarespace Online Stores, Adobe Typekit, Vimeo, Squarespace

Q: How do I contact Aeromics?

Aeromics contact info: Phone number: (203) 208-8864 Website: www.aeromics.com

Q: What does Aeromics do?

Aeromics, Inc. is a clinical-stage pharmaceutical company focused on developing innovative therapeutics targeting aquaporin-4 (AQP4) to control edema in patients suffering from severe ischemic stroke and other conditions. Their lead product, AER-271, aims to prevent brain swelling following ischemic events, significantly improving patient outcomes... and recovery times. The company is currently conducting Phase 1 clinical trials to assess the safety and tolerability of AER-271, with plans for a Phase II efficacy trial. Aeromics is dedicated to addressing critical medical needs in neurology through advanced understanding of water physiology. Read More

Q: Is Aeromics a public company?

Aeromics is private company therefore does not currently have an official ticker symbol

Manufacturing · Connecticut, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

470 James St Ste 7, New Haven, Connectic...

Phone Number

(203) 208-8864

Website

www.aeromics.com

Revenue

<$5 Million

Industry

Manufacturing

Pharmaceuticals

Business Services

Research & Development

About Aeromics

Aeromics, Inc. is a clinical-stage pharmaceutical company focused on developing innovative therapeutics targeting aquaporin-4 (AQP4) to control edema in patients suffering from severe ischemic stroke and other conditions. Their lead product, AER-271, aims to prevent brain swelling following ischemic events, significantly improving patient outcomes and recovery times. The company is currently conducting Phase 1 clinical trials to assess the safety and tolerability of AER-271, with plans for a Phase II efficacy trial. Aeromics is dedicated to addressing critical medical needs in neurology through advanced understanding of water physiology.Explore more

Is this data correct?

View contact profiles from Aeromics

SIC Code 28,283NAICS Code 32,325Show more

Aeromics Org Chart

Phone

Trevor Thompson

President

Phone

Get the full picture

Compare Similar Companies to Aeromics

Compare insights from companies similar to Aeromics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.